Differential effects of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains

Reproductive Toxicology

Volumn 27, Issue 3-4, 2009, Pages 299-306

  Yang, Chengfeng ^a   Tan, Ying S ^a   Harkema, Jack R ^a   Haslam, Sandra Z ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Hepatocellular hypertrophy; Mammary gland; Perfluorooctanoic acid (PFOA); Peripubertal exposure; Strain differences; Timing of vaginal opening; Uterus

Indexed keywords

PERFLUOROOCTANOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BREAST DEVELOPMENT; CANCER RISK; CONTROLLED STUDY; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; FEMALE; GENITAL MALFORMATION; LIVER HYPERTROPHY; MAMMARY GLAND; MOUSE; NONHUMAN; PUBERTY; STRAIN DIFFERENCE; VAGINA;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; GROWTH; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OCTANOIC ACIDS; SPECIES SPECIFICITY;

MUS;

EID: 64949137039     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2008.10.003     Document Type: Article

References (32)

1. Hekster F.M., Laane R.W., and de Voogt P. Environmental and toxicity effects of perfluoroalkylated substances. Rev Environ Contam Toxicol 179 (2003) 99-121
2. Betts K.S. Perfluoroalkyl acids: what is the evidence telling us?. Environ Health Perspect 115 (2007) A250-A256
3. Fromme H., Tittlemier S.A., Völkel W., Wilhelm M., and Twardella D. Perfluorinated compounds-exposure assessment for the general population in western countries. Int J Hyg Environ Health (2008) [Epub ahead of print]
4. Emmett E.A., Shofer F.S., Zhang H., Freeman D., Desai C., and Shaw L.M. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48 (2006) 759-770
5. Calafat A.M., Wong L.Y., Kuklenyik Z., Reidy J.A., and Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115 (2007) 1596-1602
6. Hölzer J., Midasch O., Rauchfuss K., Kraft M., Reupert R., Angerer J., et al. Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water. Environ Health Perspect 116 (2008) 651-657
7. Kudo N., and Kawashima Y. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J Toxicol Sci 28 (2003) 49-57
8. Kennedy Jr. G.L., Butenhoff J.L., Olsen G.W., O'Connor J.C., Seacat A.M., Perkins R.G., et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol 34 (2004) 351-384
9. Lau C., Butenhoff J.L., and Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198 (2004) 231-241
10. Lau C., Thibodeaux J.R., Hanson R.G., Narotsky M.G., Rogers J.M., Lindstrom A.B., et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90 (2006) 510-518
11. Wolf C.J., Fenton S.E., Schmid J.E., Calafat A.M., Kuklenyik Z., Bryant X.A., et al. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci 95 (2007) 462-473
12. White S.S., Calafat A.M., Kuklenyik Z., Villanueva L., Zehr R.D., Helfant L., et al. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 96 (2007) 133-144
13. Fenton S.E. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology 147 (2006) S18-S24
14. Selevan S.G., Kimmel C.A., and Mendola P. Identifying critical windows of exposure for children's health. Environ Health Perspect 108 Suppl. 3 (2000) 451-455
15. Banerjee M.R., Wood B.G., Lin F.K., and Crump L.R. Organ culture of whole mammary gland of the mouse. Tissue Cult Assoc Man 2 (1976) 457-462
16. Daniel C.W., and Silberstein G.B. Postnatal development of the rodent mammary gland. In: Neville M.C., and Daniel C.W. (Eds). The mammary gland: development, regulation, and function (1987), Plenum Press, New York 3-36
17. Russo J., and Russo I.H. Development of the human mammary gland. In: Neville M.C., and Daniel C.W. (Eds). The mammary gland: development, regulation, and function (1987), Plenum Press, New York 67-93
18. Russo I.H., and Russo J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenzanthracene. J Natl Cancer Inst 61 (1978) 1439-1449
19. Russo I.H., and Russo J. Experimentally induced mammary tumors in rats. Br Cancer Res Treat 39 (1996) 7-20
20. Yang Q., Xie Y., Alexson S.E., Nelson B.D., and DePierre J.W. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochem Pharmacol 63 (2002) 1893-1900
21. Abbott B.D., Wolf C.J., Schmid J.E., Das K.P., Zehr R.D., Helfant L., et al. Perfluorooctanoic acid-induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. Toxicol Sci 98 (2007) 571-581
22. Asakawa A., Toyoshima M., Harada K.H., Fujimiya M., Inoue K., and Koizumi A. The ubiquitous environmental pollutant perfluorooctanoicacid inhibits feeding behavior via peroxisome proliferator-activated receptor-alpha. Int J Mol Med 21 (2008) 439-445
23. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15 (1995) 3012-3022
24. McLachlan J.A., Simpson E., and Martin M. Endocrine disrupters and female reproductive health. Best Pract Res Clin Endocrinol Metab 20 (2006) 63-75
25. Hotckiss A.K., Rider C.V., Blystone C.R., Wilson V.S., Hartig P.C., Ankley G.T., et al. Fifteen years after "Wingspread"-environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol Sci 105 (2008) 235-259
26. Fenton S.E., Hamm J.T., Birnbaum L.S., and Youngblood G.L. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 67 (2002) 63-74
27. Jensen A.A., and Leffers H. Emerging endocrine disrupters: perfluoroalkylated substances. Int J Androl 31 (2008) 161-169
28. Maras M., Vanparys C., Muylle F., Robbens J., Berger U., Barber J.L., et al. Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation. Environ Health Perspect 114 (2006) 100-105
29. Ishibashi H., Ishida H., Matsuoka M., Tominaga N., and Arizono K. Estrogenic effects of fluorotelomer alcohols for human estrogen receptor isoforms alpha and beta in vitro. Biol Pharm Bull 30 (2007) 1358-1359
30. Wei Y., Dai J., Liu M., Wang J., Xu M., Zha J., et al. Estrogen-like properties of perfluorooctanoic acid as revealed by expressing hepatic estrogen-responsive genes in rare minnows (Gobiocypris rarus). Environ Toxicol Chem 26 (2007) 2440-2447
31. Rosen M.B., Abbott B.D., Wolf D.C., Corton J.C., Wood C.R., Schmid J.E., et al. Gene profiling in the livers of wild-type and PPAR{alpha}-null mice exposed to perfluorooctanoic acid (PFOA). Toxicol Pathol 36 (2008) 592-607
32. Rosen M.B., Lee J.S., Ren H., Vallanat B., Liu J., Waalkes M.P., et al. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR. Toxicol Sci 103 (2008) 46-56